Journal of General Virology, Vol 80, 1167-1177, Copyright © 1999 by Society for General Microbiology

ARTICLES

Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor

RI Brinkworth, DP Fairlie, D Leung and PR Young
Centre for Drug Design and Development, University of Queensland, St Lucia, Brisbane 4072, Australia

The crystal structure coordinates of the hepatitis C virus NS3 protease (HCVpro) were used to develop an homology model of the dengue 2 virus NS3 protease (DEN2pro). The amino acid sequence of DEN2pro accommodates the same alpha-helices, beta-sheets and protein-binding domains as its HCVpro counterpart, but the model predicts a number of significant differences for DEN2pro and its interactions with substrates and cofactor. Whereas HCVpro contains a Zn2+-binding site, there is no equivalent metal-binding motif in DEN2pro. It is possible that the structural role played by the zinc ion may be provided by a salt bridge between Glu93 and Lys145. The two-component viral protease comprises NS3 and a virus-encoded cofactor, NS4A for HCV and NS2B for DEN2. Previous studies have identified a central 40 amino acid cofactor domain of the dengue virus NS2B that is required for protease activity. Modelling of the putative interactions between DEN2pro and its cofactor suggests that a 12 amino acid hydrophobic region within this sequence (70-GSSPILSITISE-81) may associate directly with NS3. Modelling also suggests that the substrate binds in an extended conformation to the solvent-exposed surface of the protease, with a P1-binding site that is significantly different from its HCV counterpart. The model described in this study not only reveals unique features of the flavivirus protease but also provides a structural basis for both cofactor and substrate binding that should prove useful in the early design and development of inhibitors.

This article has been cited by other articles:

				K. J. Chappell, M. J. Stoermer, D. P. Fairlie, and P. R. Young Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity J. Gen. Virol., April 1, 2008; 89(4): 1010 - 1014. [Abstract] [Full Text] [PDF]

				B. A. M. Pastorino, C. N. Peyrefitte, M. Grandadam, M. C. E. Thill, H. J. Tolou, and M. Bessaud Mutagenesis analysis of the NS2B determinants of the Alkhurma virus NS2B-NS3 protease activation. J. Gen. Virol., November 1, 2006; 87(Pt 11): 3279 - 3283. [Abstract] [Full Text] [PDF]

				T. Castrignano, P. D. De Meo, D. Cozzetto, I. G. Talamo, and A. Tramontano The PMDB Protein Model Database Nucleic Acids Res., January 1, 2006; 34(suppl_1): D306 - D309. [Abstract] [Full Text] [PDF]

				T. J. Chambers, D. A. Droll, Y. Tang, Y. Liang, V. K. Ganesh, K. H. M. Murthy, and M. Nickells Yellow fever virus NS2B-NS3 protease: characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities J. Gen. Virol., May 1, 2005; 86(5): 1403 - 1413. [Abstract] [Full Text] [PDF]

				K. J. Chappell, T. A. Nall, M. J. Stoermer, N.-X. Fang, J. D. A. Tyndall, D. P. Fairlie, and P. R. Young Site-directed Mutagenesis and Kinetic Studies of the West Nile Virus NS3 Protease Identify Key Enzyme-Substrate Interactions J. Biol. Chem., January 28, 2005; 280(4): 2896 - 2903. [Abstract] [Full Text] [PDF]

				P. Niyomrattanakit, P. Winoyanuwattikun, S. Chanprapaph, C. Angsuthanasombat, S. Panyim, and G. Katzenmeier Identification of Residues in the Dengue Virus Type 2 NS2B Cofactor That Are Critical for NS3 Protease Activation J. Virol., December 15, 2004; 78(24): 13708 - 13716. [Abstract] [Full Text] [PDF]

				T. A. Nall, K. J. Chappell, M. J. Stoermer, N.-X. Fang, J. D. A. Tyndall, P. R. Young, and D. P. Fairlie Enzymatic Characterization and Homology Model of a Catalytically Active Recombinant West Nile Virus NS3 Protease J. Biol. Chem., November 19, 2004; 279(47): 48535 - 48542. [Abstract] [Full Text] [PDF]

				N. Shafee and S. AbuBakar Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis J. Gen. Virol., August 1, 2003; 84(8): 2191 - 2195. [Abstract] [Full Text] [PDF]

				D. Leung, K. Schroder, H. White, N.-X. Fang, M. J. Stoermer, G. Abbenante, J. L. Martin, P. R. Young, and D. P. Fairlie Activity of Recombinant Dengue 2 Virus NS3 Protease in the Presence of a Truncated NS2B Co-factor, Small Peptide Substrates, and Inhibitors J. Biol. Chem., November 30, 2001; 276(49): 45762 - 45771. [Abstract] [Full Text] [PDF]

				J. E. Blaney Jr., D. H. Johnson, C.-Y. Firestone, C. T. Hanson, B. R. Murphy, and S. S. Whitehead Chemical Mutagenesis of Dengue Virus Type 4 Yields Mutant Viruses Which Are Temperature Sensitive in Vero Cells or Human Liver Cells and Attenuated in Mice J. Virol., October 15, 2001; 75(20): 9731 - 9740. [Abstract] [Full Text] [PDF]

				A. E. Matusan, P. G. Kelley, M. J. Pryor, J. C. Whisstock, A. D. Davidson, and P. J. Wright Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus J. Gen. Virol., July 1, 2001; 82(7): 1647 - 1656. [Abstract] [Full Text] [PDF]

				N. Butkiewicz, N. Yao, W. Zhong, J. Wright-Minogue, P. Ingravallo, R. Zhang, J. Durkin, D. N. Standring, B. M. Baroudy, D. V. Sangar, et al. Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3 J. Virol., May 1, 2000; 74(9): 4291 - 4301. [Abstract] [Full Text]

				S. Butrapet, C. Y.-H. Huang, D. J. Pierro, N. Bhamarapravati, D. J. Gubler, and R. M. Kinney Attenuation Markers of a Candidate Dengue Type 2 Vaccine Virus, Strain 16681 (PDK-53), Are Defined by Mutations in the 5' Noncoding Region and Nonstructural Proteins 1 and 3 J. Virol., April 1, 2000; 74(7): 3011 - 3019. [Abstract] [Full Text]

				A. A. Khromykh, P. L. Sedlak, and E. G. Westaway cis- and trans-Acting Elements in Flavivirus RNA Replication J. Virol., April 1, 2000; 74(7): 3253 - 3263. [Abstract] [Full Text]

				R. Yusof, S. Clum, M. Wetzel, H. M. K. Murthy, and R. Padmanabhan Purified NS2B/NS3 Serine Protease of Dengue Virus Type 2 Exhibits Cofactor NS2B Dependence for Cleavage of Substrates with Dibasic Amino Acids in Vitro J. Biol. Chem., March 31, 2000; 275(14): 9963 - 9969. [Abstract] [Full Text] [PDF]